Delays in diagnosis, variations in treatment for morphea

Delays in diagnosis, variations in treatment for morphea
Patients with localized scleroderma (morphea) often experience delay in diagnosis and variability in treatment that is based more on the specialty of the provider than disease characteristics, according to a study published in the November issue of the Journal of the American Academy of Dermatology.

(HealthDay)—Patients with localized scleroderma (morphea) often experience delay in diagnosis and variability in treatment that is based more on the specialty of the provider than disease characteristics, according to a study published in the November issue of the Journal of the American Academy of Dermatology.

Weilan Johnson, M.D., from the Texas Health Presbyterian Hospital Dallas, and Heidi Jacobe, M.D., from the University of Texas Southwestern Medical Center, assessed the duration between morphea onset and diagnosis in a cohort of 224 patients. The specialty of the provider, initial evaluation, and therapy were also examined.

The researchers found that 63 percent of patients received a diagnosis more than six months after morphea onset. Most patients (83.5 percent) were diagnosed and treated by , with the more severe forms of morphea (linear and generalized) diagnosed and treated by rheumatologists. were the most commonly prescribed therapy (63 percent). Dermatologists mainly prescribed topical treatments or , even for those with linear and generalized morphea, while rheumatologists mainly prescribed systemic immunosuppressives and physical therapy.

"In summary, we identified several factors that impact the care of patients with morphea," the authors write. "These include delay in diagnosis and treatment, large variation in evaluation and therapy based on the specialty of the provider, and widespread use of evaluations and therapy with little evidence for their efficacy."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Cochrane Review of RDT for diagnosis of drug resistant TB

14 minutes ago

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, have conducted an independent review to examine the diagnostic accuracy of the GenoType MTBDRsl assay for the detection of resistance ...

Africans in New York complain of Ebola stigma

4 hours ago

Members of the west African community in New York complained Wednesday that their children were being bullied at school and businesses were losing money because of hysteria over Ebola.

Ebola expert says China at risk, seeks Japan aid

4 hours ago

A scientist who helped to discover the Ebola virus says he is concerned that the disease could spread to China given the large numbers of Chinese workers traveling to and from Africa.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.